Browse by Academic Unit (A-Z)

A

Absolom, K., Kaasa, S., Velikova, G. orcid.org/0000-0003-1899-5942 et al. (22 more authors) (2024) (101.4) A pan-European project to develop and implement a digitally supported solution to patient-centred cancer care. In: Quality of Life Research. 31st Annual Conference of the International Society for Quality of Life Research, 13 Oct 2024, Cologne, Germany. Springer , S21-S22.

Adams, R., Drinkwater, K., Gilbert, D.C. et al. (4 more authors) (2024) The Impact of National Radiotherapy Guidelines: The UK Anal Cancer Story. Clinical Oncology, 36 (10). pp. 593-595. ISSN 0936-6555

Adusumilli, P. orcid.org/0000-0002-1567-9795, Ravikumar, N. orcid.org/0000-0003-0134-107X, Hall, G. orcid.org/0000-0002-8864-5932 et al. (3 more authors) (2023) Radiomics in the evaluation of ovarian masses — a systematic review. Insights into Imaging, 14 (1). 165.

Alzahrani, N., Henry, A. orcid.org/0000-0002-5379-6618, Clark, A. et al. (3 more authors) (2023) MRI-based deep learning autocontouring: Evaluation and implementation for brain radiotherapy. In: ESTRO 2023, 12-16 May 2023, Vienna, Austria.

Alzahrani, N.M., Henry, A. orcid.org/0000-0002-5379-6618, Clark, A.K. orcid.org/0000-0003-4359-3697 et al. (3 more authors) (2023) Geometric evaluations of CT and MRI based deep learning segmentation for brain OARs in radiotherapy. Physics in Medicine & Biology, 68 (17). 175035. ISSN 0031-9155

Alzahrani, N.M., Henry, A.M. orcid.org/0000-0002-5379-6618, Clark, A.K. et al. (3 more authors) (2024) Dosimetric impact of contour editing on CT and MRI deep‐learning autosegmentation for brain OARs. Journal of Applied Clinical Medical Physics, 25 (5). e14345. ISSN 1526-9914

Amat-Fernandez, C., Garin, O., Luer-Aguila, R. et al. (22 more authors) (2025) Systematic review of the needs and health-related quality of life domains relevant to people surviving cancer in Europe. Quality of Life Research. ISSN 0962-9343

Andratschke, N., Willmann, J., Appelt, A.L. orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radio-therapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045

Andrews, L.J. orcid.org/0000-0001-5595-1987, Thornton, Z.A. orcid.org/0000-0001-9275-7198, Saleh, R. et al. (6 more authors) (2023) Genomic landscape and actionable mutations of brain metastases derived from non–small cell lung cancer: A systematic review. Neuro-Oncology Advances, 5 (1). vdad145. ISSN 2632-2498

Apolone, G., Costantini, M., Caselli, L. et al. (26 more authors) (2024) Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey. BMC Public Health, 24. 3517. ISSN 1472-698X

Arp, D.T., Appelt, A.L. orcid.org/0000-0003-2792-9218, Brøndum, R.F. et al. (3 more authors) (2024) Individual lymph node position variation for rectal cancer patients treated with long course chemoradiotherapy. Physics and Imaging in Radiation Oncology, 31. 100599. ISSN 2405-6316

Arp, D.T. orcid.org/0009-0007-7980-5539, Appelt, A.L. orcid.org/0000-0003-2792-9218, Jensen, L.H. et al. (6 more authors) (2024) Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study. Physica Medica, 118. 103206. ISSN 1120-1797

Arp, D.T., Appelt, A.L. orcid.org/0000-0003-2792-9218, Nielsen, M.S. et al. (2 more authors) (2023) Rectal tumour position variation: Systematic and random variations by point-based surface evaluation. In: Radiotherapy and Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. , S1685-S1686.

Asif, A., Chan, V.W.-S. orcid.org/0000-0002-6108-9315, Osman, F.H. et al. (12 more authors) (2023) The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Small Renal Cell Carcinomas after Image-Guided Cryoablation or Radio-Frequency Ablation. Cancers, 15 (7). 2187. ISSN 2072-6694

B

Bagger, M., Espensen, C., Rasmussen, K. et al. (4 more authors) (2023) Genetic Status Affects Disease-Specific Mortality But Not the Incidence of Local Recurrence in Patients with Uveal Melanoma. Ophthalmology, 130 (8). pp. 822-829. ISSN 0161-6420

Barrell, M., Abbott, N., Adams, R. et al. (4 more authors) (2023) Assessing plan quality in the 'PLATO anal cancer trial 5' pilot phase with automated planning. In: ESTRO 2023, 12-16 May 2023, Vienna, Austria.

Baxter, M.A. orcid.org/0000-0002-5773-8650, Spender, L.C., Walsh, S. et al. (6 more authors) (2023) Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial. Cancers, 15 (9). 2591. ISSN 2072-6694

Bedding, C., Gillanders, E., Franzoi, M.A. et al. (26 more authors) (2024) (B203.8) Measuring the quality of life of people with cancer and cancer survivors in Europe: Development of the EUonQoLKit. In: Quality of Life Research. 31st Annual Conference of the International Society for Quality of Life Research, 13 Oct 2024, Cologne, Germany. Springer , S92-S93.

Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407

Bird, D., Teo, M., Casanova, N. et al. (8 more authors) (2020) PH-0410: Multi-centre, deep learning, sCT generation for anorectal cancers with AI robustness assessment. In: Radiotherapy and Oncology. ESTRO 2020, 28 Nov - 01 Dec 2020, Online. Elsevier , s221.

Bjelic-Radisic, V., Cardoso, F., Weis, J. et al. (35 more authors) (2025) An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42. The Breast. 103890. ISSN 0960-9776

Bjelic-Radisic, V., Cardoso, F., Weis, J. et al. (17 more authors) (2024) 270MO An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: Results of the validation study phase IV EORTC QLQ-BR42. In: ESMO Open. ESMO Breast Cancer 2024, 15-17 May 2024, Berlin, Germany. Elsevier .

Boele, F.W. orcid.org/0000-0003-0409-7949, Butler, S., Nicklin, E. et al. (3 more authors) (2022) P08.05.B Communication in the context of glioblastoma treatment: what matters most to patients and caregivers. In: Neuro-Oncology. Abstracts from the 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii43-ii44.

Boele, F.W. orcid.org/0000-0003-0409-7949, Kawalek, J.C., Nicklin, E. et al. (2 more authors) (2024) Living with an artificial eye: qualitative insights into patient and family member experiences. International Ophthalmology, 44. 227. ISSN 0165-5701

Boele, F.W. orcid.org/0000-0003-0409-7949, Rudkin, S.E., Absolom, K. orcid.org/0000-0002-5477-6643 et al. (3 more authors) (2023) The experience of interval scans for adults living with primary malignant brain tumors. Supportive Care in Cancer, 31 (6). 356. ISSN 0941-4355

Bozovic Spasojevic, I. orcid.org/0000-0003-0678-9850, Ferrari, A. orcid.org/0000-0002-4724-0517, De Munter, J. et al. (12 more authors) (2023) Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey. Tumori Journal, 109 (6). 546 -554. ISSN 0300-8916

Breen, J. orcid.org/0000-0002-9020-3383, Allen, K., Zucker, K. orcid.org/0000-0003-4385-3153 et al. (5 more authors) (2023) Artificial intelligence in ovarian cancer histopathology: a systematic review. npj Precision Oncology, 7. 83. ISSN 2397-768X

Brüning-Richardson, A. orcid.org/0000-0002-9862-9805, Shaw, G. C. orcid.org/0000-0001-9344-4433, Tams, D. et al. (17 more authors) (2021) GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers, 13 (23). 5939. ISSN 2072-6694

Brüning-Richardson, A. orcid.org/0000-0002-9862-9805, Shaw, G.C. orcid.org/0000-0001-9344-4433, Tams, D. et al. (17 more authors) (2022) Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers, 14 (15). 3789. ISSN 2072-6694

Brüning-Richardson, A. orcid.org/0000-0002-9862-9805, Shaw, G.C. orcid.org/0000-0001-9344-4433, Tams, D. et al. (17 more authors) (2022) Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers, 14 (15). 3789. ISSN 2072-6694

C

Calvert, M.J., Cruz, S., Retzer, A. et al. (19 more authors) (2023) Patient reported outcome assessment must be inclusive and equitable. In: 6th National Patient Reported Outcome Measures (PROMs) Annual UK Research Virtual Conference, 14-15 Jun 2022, Bridgend + Virtual.

Chan, V.W.-S. orcid.org/0000-0002-6108-9315, Osman, F.H., Cartledge, J. et al. (9 more authors) (2022) Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma. European Radiology, 32 (9). pp. 5811-5820. ISSN 0938-7994

Chuter, R., Glassborow, E., Speight, R. et al. (9 more authors) (2022) A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence. Physics and Imaging in Radiation Oncology, 21. pp. 78-83. ISSN 2405-6316

Clark, A.K. orcid.org/0000-0003-4359-3697, Wright, G., Mason, J. et al. (4 more authors) (2023) Single- and dual-source-strength focal boost planning in low-dose-rate prostate brachytherapy: feasibility study. Journal of Radiotherapy in Practice, 22. e106. ISSN 1460-3969

Cornford, P., van den Bergh, R.C.N., Briers, E. et al. (28 more authors) (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology, 86 (2). pp. 148-163. ISSN 0302-2838

Corrado, J., Halpin, S. orcid.org/0000-0002-0417-8928, Preston, N. orcid.org/0000-0001-8429-7320 et al. (7 more authors) (2022) HEART rate variability biofeedback for long COVID symptoms (HEARTLOC): protocol for a feasibility study. BMJ Open, 12 (11). e066044. ISSN 2044-6055

Crossfield, S.S.R. orcid.org/0000-0001-7337-3527, Zucker, K. orcid.org/0000-0003-4385-3153, Baxter, P. orcid.org/0000-0003-2699-3103 et al. (6 more authors) (2022) A data flow process for confidential data and its application in a health research project. PLOS ONE, 17 (1). e0262609. ISSN 1932-6203

Crossnohere, N., Anderson, N., Baumhauer, J. et al. (15 more authors) (2024) HSD71 Implementing Patient-Reported Outcomes in Clinical Practice: The PROTEUS-Practice Framework & Guide. In: ISPOR 2024, 05-08 May 2024, Atlanta, USA.

Crossnohere, N.L. orcid.org/0000-0002-2811-1330, Anderson, N., Baumhauer, J. orcid.org/0000-0003-2142-7778 et al. (15 more authors) (2024) A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide. Nature Medicine, 30. pp. 1519-1520. ISSN 1078-8956

Currie, S. orcid.org/0000-0002-0154-6588, Fatania, K. orcid.org/0000-0003-2421-1083, Frood, R. orcid.org/0000-0003-2681-9922 et al. (11 more authors) (2023) Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study. Current Oncology, 30 (7). pp. 6682-6698. ISSN 1198-0052

Currie, S., Fatania, K., Matthew, R. et al. (4 more authors) (2022) A Comprehensive Clinical Review of Adult-Type Diffuse Glioma Incorporating the 2021 World Health Organization Classification. Neurographics, 12 (2). pp. 43-70. ISSN 2637-8329

D

Dawkins, B. orcid.org/0000-0002-7038-1975, Absolom, K. orcid.org/0000-0002-5477-6643, Hewison, J. orcid.org/0000-0003-3026-3250 et al. (13 more authors) (2024) Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy. JCO Oncology Practice. ISSN 2688-1527

Diez, P., Hanna, G.G., Aitken, K.L. et al. (18 more authors) (2022) UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. Clinical Oncology, 34 (5). pp. 288-300. ISSN 0936-6555

Domingo, E., Rathee, S., Blake, A. et al. (18 more authors) (2021) Abstract LB129: Stratification of radiotherapy and fluoropyrimidine-based chemotherapy from multi-omic profiling in rectal cancer biopsies. In: Cancer Research. AACR Annual Meeting 2021, 17-21 May 2021, Philadelphia, PA, USA. American Association for Cancer Research (AACR) , LB129.

de Ligt, K.M., Koppert, L.B., de Rooij, B.H. et al. (3 more authors) (2024) Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now. The Breast, 74. 103676. ISSN 0960-9776

de Ligt, K.M., de Rooij, B.H., Koppert, L.B. et al. (3 more authors) (2023) Patient-reported outcome measures to improve the care continuum for patients with metastatic breast cancer: opportunities and implications for nursing practice. Seminars in Oncology Nursing, 39 (6). 151510. ISSN 0749-2081

E

Elhaminia, B., Gilbert, A. orcid.org/0000-0002-9142-1227, Frangi, A.F. orcid.org/0000-0002-2675-528X et al. (5 more authors) (2023) Deep learning with visual explanation for radiotherapy-induced toxicity prediction. In: Iftekharuddin, K.M. and Chen, W., (eds.) Medical Imaging 2023: Computer-Aided Diagnosis. SPIE Medical Imaging, 19-24 Feb 2023, San Diego, CA, USA. SPIE . ISBN 9781510660359

F

Fatania, K. orcid.org/0000-0003-2421-1083, Frood, R. orcid.org/0000-0003-2681-9922, Mistry, H. orcid.org/0000-0002-9683-1903 et al. (4 more authors) (2024) Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers, 16 (7). 1301. ISSN 2072-6694

Fatania, K. orcid.org/0000-0003-2421-1083, Frood, R. orcid.org/0000-0003-2681-9922, Tyyger, M. et al. (16 more authors) (2022) Exploratory Analysis of Serial 18F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma. Cancers, 14 (14). 3485. ISSN 2072-6694

Ferrari, A., Stark, D. orcid.org/0000-0002-6172-733X, Peccatori, F.A. et al. (16 more authors) (2021) Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE). ESMO Open, 6 (2). ARTN 100096. ISSN 2059-7029

Fornacon-Wood, I., Nuamek, T., Hudson, E.M. et al. (9 more authors) (2024) Analyzing patient-reported outcome data in oncology care. International Journal of Radiation Oncology • Biology • Physics. ISSN 0360-3016

Frances, S.M., Murray, L., Nicklin, E. et al. (2 more authors) (2024) Long-term health-related quality of life in meningioma survivors: a mixed-methods systematic review. Neuro-Oncology Advances. ISSN 2632-2498

Frood, R. orcid.org/0000-0003-2681-9922, Mercer, J., Brown, P. et al. (4 more authors) (2024) Training and external validation of pre-treatment FDG PET-CT-based models for outcome prediction in anal squamous cell carcinoma. European Radiology, 34 (5). pp. 3194-3204. ISSN 0938-7994

G

Gilbert, A. orcid.org/0000-0002-9142-1227, Samuel, R., Cagney, D. et al. (3 more authors) (2024) The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review. Journal of the National Cancer Institute, 116 (8). pp. 1220-1229. ISSN 0027-8874

Gilbert, A. orcid.org/0000-0002-9142-1227, Webster, J., Brown, S. et al. (8 more authors) (2022) OC-0269 Standard vs dose escalated chemoradiotherapy in anal cancer: Phase II results of the PLATO-ACT5 RCT. Radiotherapy & Oncology, 170 (1). s225-s226. ISSN 0167-8140

Gilbert, A. orcid.org/0000-0002-9142-1227, Webster, J., Brown, S. et al. (9 more authors) (2023) OC-0831 Standard vs dose reduced chemoradiotherapy in anal cancer: short-term results of the PLATO-ACT4 RCT. Radiotherapy & Oncology, 182 (1). s702-s703. ISSN 0167-8140

Goldberg, I., Sherwood, P., Sereika, S. et al. (6 more authors) (2023) Predictors of Healthcare Utilization in Family Caregivers of Persons With a Primary Malignant Brain Tumor. Journal of Neuroscience Nursing. ISSN 0888-0395

Gooding, K.M., Lienczewski, C., Papale, M. et al. (32 more authors) (2020) Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol. BMC Nephrology, 21 (1). ARTN 242. ISSN 1471-2369

Gout, T., Zoltie, T., Woodward, A. orcid.org/0000-0002-9579-4012 et al. (10 more authors) (2023) A cross-over, randomised feasibility study of digitally printed versus hand-painted artificial eyes in adults: PERSONAL-EYE-S - a study protocol [version 2; peer review: 2 approved]. NIHR Open Research, 2 (50). ISSN 2633-4402

Graham, C.D., Ellison, R., Hall, L.H. orcid.org/0000-0001-9032-4540 et al. (18 more authors) (2024) Poster Session A: Acceptance And Commitment Therapy For Medication Decision-Making And Quality Of Life In Breast Cancer: A Randomized Pilot Trial. In: Annals of Behavioral Medicine. 2024 SBM Annual Meeting, 13-16 Mar 2024, Philadelphia, PA, USA. Oxford University Press , S19.

Green, S.M.C. orcid.org/0000-0002-2622-5377, Hall, L.H., Rousseau, N. et al. (17 more authors) (2023) Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trial. NIHR Open Research, 3 (3). ISSN 2633-4402

Green, S.M.C., Rousseau, N., Hall, L.H. et al. (17 more authors) (2024) Acceptability of a medication adherence intervention in breast cancer: a fractional factorial pilot trial process evaluation. In: 2024 SBM Annual Meeting, 13-16 Mar 2024, Philadelphia, PA.

H

Hanna, D., Merrick, S., Ghose, A. et al. (24 more authors) (2024) Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. British Journal of Cancer, 130 (12). pp. 1916-1920. ISSN 0007-0920

Hardcastle, N., Vasquez Osorio, E., Jackson, A. et al. (27 more authors) (2024) Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios. Radiotherapy and Oncology, 194. 110184. ISSN 0167-8140

Harkness, R., Frangi, A.F. orcid.org/0000-0002-2675-528X, Zucker, K. orcid.org/0000-0003-4385-3153 et al. (1 more author) (2023) Learning disentangled representations for explainable chest x-ray classification using Dirichlet VAEs. In: Išgum, I. and Colliot, O., (eds.) Medical Imaging 2023: Image Processing. SPIE Medical Imaging, 19-24 Feb 2023, San Diego, CA, USA. SPIE . ISBN 978-1-5106-6033-5

Harper-Wynne, C., Owen, J., Velikova, G. orcid.org/0000-0003-1899-5942 et al. (3 more authors) (2023) A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2+unresectable locally advanced or metastatic breast cancer (aBC): Interim results of the ESTHER study (NCT02393924). In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, IL. American Society of Clinical Oncology , Alexandria, Virginia, USA .

Hartup, S., Johnson, M., Briggs, M. et al. (2 more authors) (2022) Developing and testing a web-based intervention to support pain and symptom self-management in breast cancer surgery. In: European Journal of Surgical Oncology. Association of Breast Surgery Conference 2022, 16-17 May 2022, Liverpool, UK. Elsevier , e193-e193.

Hartup, S.M., Ashley, L., Briggs, M. et al. (2 more authors) (2023) Developing and feasibility testing a web-based intervention (ePainQ) to support post-operative pain and symptom self-management following surgery for breast cancer. In: Cancer Research. 2022 San Antonio Breast Cancer Symposium, 06-10 Dec 2022, San Antonio, Texas. Poster Session Abstracts, 83 (5). American Association for Cancer Research , Philadelphia, Pennsylvania .

Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.

Haverman, L., Luijten, M.A.J., Blackford, A.L. et al. (7 more authors) (2024) Truth and Dare: Patients Dare To Tell The Truth When Using PROMs in Clinical Practice. Quality of Life Research, 33. pp. 3299-3307. ISSN 0962-9343

Henry, A. orcid.org/0000-0002-5379-6618, Holch, P., Routledge, J. et al. (6 more authors) (2021) Pilot randomised trial of online self-monitoring of symptoms during pelvic radiotherapy. In: International Journal of Radiation Oncology, Biology, Physics. ESTRO 2020, 2020-11-28 - 2020-12-1, Vienna, Austria. Proffered Papers: Proffered papers 14: QoL and PROMs, 152 (Supplement 1). Elsevier , S164-S165.

Holch, P. orcid.org/0000-0002-4255-8315, Turner, G., Keetharuth, A.D. et al. (3 more authors) (2023) The impact of COVID-19 on PRO development, collection and implementation: views of UK and Ireland professionals. Journal of Patient-Reported Outcomes, 7. 121. ISSN 2509-8020

Horne, A., Ali, A., Brown, S. et al. (28 more authors) (2022) 153 CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). In: 20th Annual British Thoracic Oncology Group Conference 2022, 27-28 Jan 2022, Virtual.

Horne, A., Brown, S., Butterworth, K. et al. (26 more authors) (2022) EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 17 (9). s267-s268. ISSN 1556-0864

Huddart, R., Birtle, A., Cheung, K.C. et al. (19 more authors) (2023) Randomised phase II trial of adaptive image guided bladder radiotherapy: Disease control data. In: Radiotherapy & Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. Elsevier , S704-S705.

Huddart, R., Birtle, A., Cheung, K.C. et al. (19 more authors) (2023) Randomised phase II trial of adaptive image guided bladder radiotherapy: patient reported outcomes. In: Radiotherapy & Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. Elsevier , S331-S332.

Huddart, R., Hafeez, S., Griffin, C. et al. (24 more authors) (2025) Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial. European Urology, 87 (1). pp. 60-70. ISSN 0302-2838

Huddart, R., Hafeez, S., Omar, A. et al. (25 more authors) (2023) Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial. Clinical Oncology, 35 (9). pp. 586-597. ISSN 0936-6555

Huddart, R.A., Hafeez, S., Omar, A. et al. (17 more authors) (2023) Randomised phase II trial of adaptive image guided radiotherapy in muscle invasive bladder cancer: Late toxicity and cancer outcomes. In: Journal of Clinical Oncology. 2023 ASCO Genitourinary Cancers Symposium, 16-18 Feb 2023. American Society of Clinical Oncology .

Hudson, E.M. orcid.org/0000-0001-8758-7163, Noutch, S., Webster, J. et al. (15 more authors) (2024) Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) – protocol for a multi-centre open-label randomised trial. BMJ Open, 14 (3). e078926. ISSN 2044-6055

Hudson, E.M. orcid.org/0000-0001-8758-7163, Slevin, F. orcid.org/0000-0002-7176-904X, Biscombe, K. orcid.org/0009-0002-9298-3093 et al. (7 more authors) (2024) Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled Trials. Clinical Oncology, 36 (2). pp. 70-79. ISSN 0936-6555

Hughes, L., Taylor, R.M. orcid.org/0000-0002-0853-0925, Beckett, A.E. orcid.org/0000-0001-5233-3390 et al. (7 more authors) (2024) The Emotional Impact of a Cancer Diagnosis: A Qualitative Study of Adolescent and Young Adult Experience. Cancers, 16 (7). 1332. ISSN 2072-6694

Hughes, N.F. orcid.org/0000-0003-2956-1760, Cromie, K.J. orcid.org/0000-0002-2859-5291, Feltbower, R.G. orcid.org/0000-0002-1728-9408 et al. (2 more authors) (2024) Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data. International Journal of Cancer, 154 (5). pp. 816-829. ISSN 0020-7136

Hughes, N.F., Fern, L.A., Polanco, A. et al. (7 more authors) (2023) Patient and public involvement to inform priorities and practice for research using existing healthcare data for children’s and young people’s cancers. Research Involvement and Engagement, 9 (1). 71. ISSN 2056-7529

Huynh, K.A. orcid.org/0000-0002-7137-1074, Coopmans, E.C. orcid.org/0000-0003-4780-2468, Zamanipoor Najafabadi, A.H. orcid.org/0000-0003-2400-2070 et al. (13 more authors) (2023) Correction to: Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of Neuro-Oncology, 161 (2). p. 371. ISSN 0167-594X

Huynh, K.A. orcid.org/0000-0002-7137-1074, Coopmans, E.C. orcid.org/0000-0003-4780-2468, Zamanipoor Najafabadi, A.H. orcid.org/0000-0003-2400-2070 et al. (13 more authors) (2023) Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of Neuro-Oncology, 161 (2). pp. 357-370. ISSN 0167-594X

I

Iyizoba-Ebozue, Z., Nicklin, E., Price, J. orcid.org/0000-0002-3325-2488 et al. (9 more authors) (2024) “Why am I still suffering?”: Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy. Technical Innovations and Patient Support in Radiation Oncology, 30. 100241. ISSN 2405-6324

Iyizobane Ebozue, Z., Prestwich, R., Brown, S. orcid.org/0000-0002-7975-7537 et al. (7 more authors) (2023) Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic review. Radiotherapy and Oncology, 188. 109863. ISSN 0167-8140

J

Jensen, L.H., Risum, S., Nielsen, J.D. et al. (9 more authors) (2022) Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial. In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 2022-06-03 2022-06-08, Chicago, IL, USA/Online. American Society of Clinical Oncology , LBA3514.

K

Khoury, E.G. orcid.org/0000-0003-2559-2762, Nuamek, T., Heritage, S. et al. (11 more authors) (2023) Geriatric Oncology as an Unmet Workforce Training Need in the United Kingdom—A Narrative Review by the British Oncology Network for Undergraduate Societies (BONUS) and the International Society of Geriatric Oncology (SIOG) UK Country Group. Cancers, 15 (19). 4782. ISSN 2072-6694

King, M.T. orcid.org/0000-0001-7192-2887, Revicki, D.A. orcid.org/0000-0001-6780-0019, Norman, R. orcid.org/0000-0002-3112-3893 et al. (27 more authors) (2024) United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument. PharmacoEconomics - Open, 8 (1). pp. 49-63. ISSN 2509-4262

Kirton, L., Apps, J., Lawson, A. et al. (16 more authors) (2024) CTNI-16. Monogerm, a novel proof-of-principle Bayesian phase II trial design of carboplatin or vinblastine monotherapy induction prior to radiotherapy for intracranial germinoma. In: 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, 21-24 Nov 2024, Houston, Texas.

L

Lafarge, M.W. orcid.org/0000-0001-9235-783X, Domingo, E. orcid.org/0000-0003-4390-8767, Sirinukunwattana, K. et al. (17 more authors) (2024) Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy. npj Precision Oncology, 8. 89. ISSN 2397-768X

Lee, M., Abrams, K., Baird, A.M. et al. (17 more authors) (2023) EHTA307 Evolving Principles for Defining and Assessing the Economic and Societal Value of Cancer Therapies. In: Value in Health. ISPOR Europe 2023, 11-15 Nov 2023. , S380-S380.

Lee, M., Abrams, K., Baird, A.M. et al. (17 more authors) (2023) HTA307 Evolving Principles for Defining and Assessing the Economic and Societal Value of Cancer Therapies. In: Value in Health. ISPOR Europe 2023, 11-15 Nov 2023, Copenhagen, Denmark. Elsevier , s380-s380.

Lee, M., Baird, A.-M., Brown, S. et al. (17 more authors) (2023) The evolving value assessment of cancer therapies: Principles from the cancer community. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, IL. American Society of Clinical Oncology , Alexandria, Virginia, USA .

Lee, M., Larose, H. orcid.org/0000-0003-4678-6048, Gräbeldinger, M. et al. (20 more authors) (2024) The evolving value assessment of cancer therapies: Results from a modified Delphi study. Health Policy OPEN, 6. 100116. ISSN 2590-2296

Lilley, J. and Murray, L.J. orcid.org/0000-0003-0658-6455 (2023) Radiotherapy: technical aspects. Medicine, 51 (1). pp. 11-16. ISSN 1357-3039

Lorenzo Polo, A., Nix, M. orcid.org/0000-0001-7228-7344, Thompson, C. et al. (6 more authors) (2024) Improving hybrid image and structure-based deformable image registration for large internal deformations. Physics in Medicine & Biology, 69 (9). 095011. ISSN 0031-9155

M

Mahmood, U. orcid.org/0000-0002-2926-3205, Blake, A. orcid.org/0000-0002-8154-6253, Rathee, S. orcid.org/0000-0002-2853-0842 et al. (18 more authors) (2024) Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures. Cancer Research Communications, 4 (7). pp. 1765-1776. ISSN 2767-9764

Marijnen, C., de Wilt, J., Bach, S. et al. (16 more authors) (2023) OC-0272 Organ preservation in rectal cancer: the randomised STAR-TREC phase II trial. In: Radiotherapy and Oncology. ESTRO 2023, 13/05/2023 -16/05/2023, Vienna, Austria. Elsevier .

Marijnen, C., de Wilt, J., Bach, S. et al. (16 more authors) (2023) OC-0272 Organ preservation in rectal cancer: the randomised STAR-TREC phase II trial. In: Radiotherapy and Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. Elsevier , S207-S208.

Marra, G., van Leenders, G.J.L.H., Zattoni, F. et al. (31 more authors) (2023) Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review. European Urology, 84 (1). pp. 65-85. ISSN 0302-2838

McKigney, N., Collaborators, L.-Q., Velikova, G. orcid.org/0000-0003-1899-5942 et al. (2 more authors) (2024) Cross-Cultural Adaptation of the Locally Recurrent Rectal Cancer – Quality of Life (LRRC-QoL) Questionnaire for use in 14 Countries. In: European Journal of Surgical Oncology. ESSO Congress 2024, 2024-10-02 - 03-10-24, Antwerp, Belgium. Elsevier , p. 107189.

McKigney, N., Collaborators, L.-Q., Velikova, G. orcid.org/0000-0003-1899-5942 et al. (2 more authors) (2024) International Validation of the Locally Recurrent Rectal Cancer – Quality of Life (LRRC-QoL) Measure. In: European Journal of Surgical Oncology. BASO Annual Scientific Meeting, 06-07 Nov 2023, London, UK. Elsevier .

McKigney, N., Downing, A. orcid.org/0000-0002-0335-7801, Velikova, G. orcid.org/0000-0003-1899-5942 et al. (2 more authors) (2024) Registry-based study comparing health-related quality of life between patients with primary rectal cancer and locally recurrent rectal cancer. European Journal of Surgical Oncology, 50 (12). 108736. ISSN 0748-7983

McWilliam, A., Palma, G., Abravan, A. et al. (11 more authors) (2023) Voxel-based analysis: Roadmap for clinical translation. Radiotherapy and Oncology, 188. 109868. ISSN 0167-8140

Mortensen, H.R., Populaire, P., Hoffmann, L. et al. (33 more authors) (2024) Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. Radiotherapy and Oncology, 190. 109980. ISSN 0167-8140

Motzer, R.J., Porta, C., Eto, M. et al. (238 more authors) (2024) Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of Clinical Oncology, 42 (11). pp. 1222-1228. ISSN 0732-183X

Mukherjee, S., Hurt, C., Cox, C. et al. (17 more authors) (2020) Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial. In: Journal of Clinical Oncology. 2020 Gastrointestinal Cancers Symposium, 23-25 Jan 2020, San Francisco, CA, USA. American Society of Clinical Oncology , p. 373.

Mukherjee, S., Qi, C., Shaw, R. et al. (20 more authors) (2024) Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial. European Journal of Cancer, 209. 114236. ISSN 0959-8049

Murray, L. orcid.org/0000-0003-0658-6455, Thompson, C., Pagett, C. et al. (9 more authors) (2023) Treatment plan optimisation for reirradiation. Radiotherapy and Oncology, 182. 109545. ISSN 0167-8140

N

Ng, H., Chan, V.W.-S. orcid.org/0000-0002-6108-9315, Cartledge, J. et al. (8 more authors) (2021) Iatrogenic ureteric stricture post image guided renal cryoablation in a patient with von hippel-lindau syndrome. Radiology Case Reports, 16 (8). pp. 1980-1984. ISSN 1930-0433

Ng, H., Wang, K., Cartledge, J. et al. (11 more authors) (2020) Urinothorax following percutaneous image-guided renal cryoablation. Radiology Case Reports, 15 (11). pp. 2348-2352. ISSN 1930-0433

Nicklin, E., Jopson, J. and Boele, F. orcid.org/0000-0003-0409-7949 (2022) P08.09.A Improving support for family carers: Creating a cross-sector collaborative working group. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii44-ii45.

Nicklin, E., Phang, I., Short, S. orcid.org/0000-0003-4423-7256 et al. (2 more authors) (2022) QOL-19. RETURNING TO WORK AFTER A BRAIN TUMOUR – “I THOUGHT I WOULD BE BACK AT WORK THE NEXT WEEK, HOW WRONG I WAS!”. In: Neuro-Oncology. 27th Annual Meeting and Education Day of the Society for Neuro-Oncology, 16-20 Nov 2022, Florida, USA. Oxford University Press , vii245-vii245.

Nicklin, E. orcid.org/0000-0002-6683-8098, Phang, I. orcid.org/0000-0002-1516-3043, Short, S.C. orcid.org/0000-0003-4423-7256 et al. (2 more authors) (2023) Patient and caregiver return to work after a primary brain tumour. Neuro-Oncology Practice. npad039. ISSN 2054-2577

Ní Leathlobhair, M., Frangou, A., Kinnersley, B. et al. (24 more authors) (2024) Genomic landscape of adult testicular germ cell tumours in the 100,000 Genomes Project. Nature Communications, 15. 9247. ISSN 2041-1723

O

O'Cathail, S.M., Adams, R., Hawkins, M.A. et al. (3 more authors) (2023) Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea. Clinical and Translational Radiation Oncology, 43. 100672. ISSN 2405-6308

Oort, Q., Koekkoek, J., Aaronson, N.K. et al. (21 more authors) (2022) PL02.4.A International validation study of an EORTC instrument measuring instrumental activities of daily living (IADL) in patients with brain tumours: EORTC IADL-BN32. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii3-ii3.

Ozcan, B.B., Zeitouni, L., Santos, J.M.M.M. et al. (54 more authors) (2024) Trainee Research Prizes from the 2023 RSNA Scientific Assembly and Annual Meeting. Radiological Society of North America (RSNA).

P

Parker, C.C. orcid.org/0000-0001-6512-124X, Petersen, P.M., Cook, A.D. orcid.org/0000-0003-4417-2632 et al. (55 more authors) (2024) Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047). Annals of Oncology, 35 (7). pp. 656-666. ISSN 0923-7534

Pearce, J., Clegg, A., Velikova, G. orcid.org/0000-0003-1899-5942 et al. (2 more authors) (2023) SIOG2023-4-P-267 - Introducing the Frailty-inforRmed cAncer ManagemEnt (FRAME) intervention development study. In: Journal of Geriatric Oncology. SIOG 2023 Annual Conference, 09-11 Nov 2023, Valencia, Spain. Elsevier , s36-s37.

Pearce, J., Martin, S., Clegg, A. et al. (3 more authors) (2023) SIOG2023-2-P-218 - A systematic review of the association between baseline frailty measures and SACT outcomes. In: Journal of Geriatric Oncology. SIOG 2023 Annual Conference, 09-11 Nov 2023, Valencia, Spain. Elsevier , s16-s16.

Pearce, J., Swinson, D., Cairns, D. orcid.org/0000-0002-2338-0179 et al. (6 more authors) (2021) SIOG2021-0064* - Frailty and treatment outcome in advanced gastro-oesophageal cancer: an exploratory analysis of the GO2 trial. In: Journal of Geriatric Oncology. SIOG 2021, 04-05 Nov 2021, Virtual. Elsevier , s35.

Perry, M.B. orcid.org/0009-0002-2978-2272, Taylor, S., Khatoon, B. et al. (6 more authors) (2023) Effectiveness of electronic patient-reported outcomes in people with cancer: a systematic review and meta-analysis. [Preprint]

Piil, K. and Boele, F. orcid.org/0000-0003-0409-7949 (2023) Paving the Way to Evidence-Based Clinical Practice: Establishing Effective Caregiver and Family Support Interventions. Neuro-Oncology Practice, 10 (6). pp. 504-505. ISSN 2054-2577

Platt, J.R. orcid.org/0000-0003-0974-456X, Allotey, J. orcid.org/0009-0001-1419-5617, Alouani, E. orcid.org/0000-0002-2303-118X et al. (18 more authors) (2024) Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series. ESMO Open, 9 (9). 103698. ISSN 2059-7029

Platt, J.R. orcid.org/0000-0003-0974-456X, Pennycook, S., Muthoo, C.E. et al. (6 more authors) (2025) Colon cancer biology and treatment in the era of precision oncology: A primer for Radiologists. European Journal of Radiology, 185. 112000. ISSN 0720-048X

Platt, J.R., Williams, C. orcid.org/0000-0002-1574-653X, West, N. orcid.org/0000-0002-0346-6709 et al. (2 more authors) (2023) Exploring the radiological differences of lymph nodes between mismatch repair deficient and mismatch repair proficient colon cancer. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .

Portner, R., McWilliam, A., Zhong, J. et al. (16 more authors) (2022) Prostate Magnetic Resonance Imaging Delta-Radiomics during Image-Guided Conventional Fractionation and Stereotactic Ablative Radiotherapy. In: UNSPECIFIED.

R

Rajeswaran, T., Gojsevic, M., Chan, A.W. et al. (20 more authors) (2024) Quality of life issues in patients with ductal carcinoma in situ: a systematic review. Supportive Care in Cancer, 32 (695). ISSN 0941-4355

Rescigno, P., Porta, N., Finneran, L. et al. (26 more authors) (2024) Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. European Journal of Cancer, 205. 114103. ISSN 0959-8049

Riber, L., Appelt, A.L. orcid.org/0000-0003-2792-9218, Fokdal, L. et al. (2 more authors) (2023) PO-1398 Long term urinary function after preoperative radio(chemo)therapy in locally advanced rectal cancer. In: Radiotherapy and Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. Elsevier , S1127-S1128.

Riviere-Cazaux, C. orcid.org/0000-0002-8857-4345, Carlstrom, L.P., Neth, B.J. et al. (17 more authors) (2023) An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence. npj Precision Oncology, 7 (1). 126. ISSN 2397-768X

Robins, V.R., Gelcich, S., Absolom, K. orcid.org/0000-0002-5477-6643 et al. (1 more author) (2024) The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: A systematic review. The Breast, 76. 103734. ISSN 0960-9776

Rogers, Z., Glaser, A., Catto, J.W.F. et al. (17 more authors) (2023) Quality of life after a diagnosis of Bladder Cancer: Longitudinal survey over the first year. BJU International. ISSN 1464-4096

Rudkin, S., Booth, T.C., Absolom, K. orcid.org/0000-0002-5477-6643 et al. (3 more authors) (2022) OS09.5.A The experience of interval scans for adults living with primary malignant brain tumours. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii20-ii20.

Russell, E., O’Hara, C., Andersson, S. et al. (4 more authors) (2024) An automated assessment pipeline to identify prostate treatments that need adaptive radiotherapy. Journal of Radiotherapy in Practice, 23. e29. ISSN 1460-3969

S

Schytte, T., Kristiansen, C., Khalil, A. et al. (17 more authors) (2024) Overall survival following heterogeneous FDG-guided dose-escalation for locally advanced NSCLC in the international phase III NARLAL2 trial. Journal of Clinical Oncology, 42 (17_suppl). ISSN 0732-183X

Sebag-Montefiore, D. orcid.org/0000-0002-5978-9259, Adams, R., Gollins, S. et al. (17 more authors) (2020) ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC). Journal of Clinical Oncology, 38 (15_suppl). 4101. ISSN 0732-183X

Seligmann, J., Morton, D., Seymour, M. et al. (11 more authors) (2023) 552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel. In: Annals of Oncology. ESMO Congress 2023, 2023-10-20 2023-10-24, Madrid, Spain. Elsevier , S412-S412.

Shah, N., Sebag-Montefiore, D. orcid.org/0000-0002-5978-9259, Cervantes, A. et al. (2 more authors) (2023) Preoperative Treatment of Locally Advanced Rectal Cancer. New England Journal of Medicine, 389 (17). pp. 1630-1632. ISSN 0028-4793

Shen, Z., Brand, D., Zhang, Y. et al. (12 more authors) (2023) Modeling Acute Chemoradiotherapy (CRT) Diarrhea Severity Using Automatically Contoured Small Bowel. In: International Journal of Radiation Oncology - Biology - Physics. ASTRO 2023: 65th Annual Meeting, 01-04 Oct 2023, San Diego, CA, USA. Elsevier , E338.

Short, S. orcid.org/0000-0003-4423-7256, Kendall, J., West, E. orcid.org/0000-0001-7449-120X et al. (7 more authors) (2022) P11.64.A Long-term follow up and translational data from the ReoGlio phase Ib trial of GM-CSF and intravenous pelareorep (Reovirus) alongside standard of care in GBM. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii73-ii73.

Slevin, F. orcid.org/0000-0002-7176-904X, Aitken, K., Alongi, F. et al. (24 more authors) (2021) An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation. Radiotherapy and Oncology, 164. pp. 104-114. ISSN 0167-8140

Slevin, F., Beasley, M., Zhong, J. orcid.org/0000-0001-5325-3739 et al. (5 more authors) (2022) A feasibility trial of Buscopan to improve cone-beam CT during abdominal/pelvic SABR. Clinical Oncology (Wormald abstract Competition 2021), 34 (2). ISSN 0936-6555

Slevin, F. orcid.org/0000-0002-7176-904X, Thompson, C.M., Speight, R. et al. (3 more authors) (2021) Ultra hypofractionated extended nodal irradiation using volumetric modulated arc therapy for oligorecurrent pelvic nodal prostate cancer. Medical Dosimetry, 46 (4). pp. 411-418. ISSN 0958-3947

Slevin, F. orcid.org/0000-0002-7176-904X, Zattoni, F., Checcucci, E. et al. (27 more authors) (2024) A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer. European Urology Oncology, 7 (4). pp. 677-696. ISSN 2588-9311

Smith, S.G., Green, S.M.C., McNaught, E. et al. (21 more authors) (2024) Optimizing an intervention to support medication adherence in women with early stage breast cancer: the ROSETA pilot trial. In: 2024 SBM Annual Meeting, 13-16 Mar 2024, Philadelphia, PA.

Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.

Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) "Sometimes We Think About It But Don't Talk About It" Asking Adolescents And Young Adults With Cancer To Evaluate Sensitive Areas Of Life. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S17-S17.

Stranne, J., Henry, A. orcid.org/0000-0002-5379-6618 and Oprea-Lager, D.E. (2025) Use of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Nodal Staging in Prostate Cancer and Tailoring of Treatment: A Continuing Conundrum. European Urology, 87 (2). pp. 108-109. ISSN 0302-2838

Swinton, M., Portner, R., Brooks, L. et al. (8 more authors) (2023) MR Delta Radiomics during Radiotherapy to Prostate Cancer: Does Dose per Fraction Matter? In: ESTRO 2023, 13-16 May 2023, Vienna, Austria.

T

Tanner, G., Finetti, M.A., Pollock, S. et al. (13 more authors) (2022) IDHwt Glioblastomas Show Opposing Resistance Mechanisms Across Patients in Response to Standard Treatment. In: BNOS 2022, 22-24 Jun 2022, Liverpool.

Taylor, R.M. orcid.org/0000-0002-0853-0925, Whelan, J.S. orcid.org/0000-0001-6793-5722, Barber, J.A. orcid.org/0000-0001-5762-762X et al. (5 more authors) (2024) The Impact of Specialist Care on Teenage and Young Adult Patient-Reported Outcomes in England: A BRIGHTLIGHT Study. Journal of Adolescent and Young Adult Oncology, 13 (3). 492 -501. ISSN 2156-5333

Theophanous, S., Samuel, R., Lilley, J. et al. (4 more authors) (2022) PO-1321 Prognostic factors for anal cancer treated with conformal radiotherapy – a systematic review. In: Radiotherapy and Oncology. ESTRO 2022, 06-10 May 2022, Copenhagen, Denmark/Online. Elsevier , S1115-S1116.

Thiruthaneeswaran, N., Bibby, B.A.S., Pereira, R. et al. (8 more authors) (2020) The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. In: Radiotherapy & Oncology. ESTRO 2020, 28 Nov - 01 Dec 2020, Online. Elsevier , S1086-S1087.

Thompson, C., Pagett, C. orcid.org/0000-0001-8096-3875, Lilley, J. orcid.org/0000-0003-0060-0316 et al. (7 more authors) (2023) Brain Re-Irradiation Robustly Accounting for Previously Delivered Dose. Cancers, 15 (15). 3831. ISSN 2072-6694

Tilki, D., van den Bergh, R.C.N., Briers, E. et al. (28 more authors) (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. European Urology, 86 (2). pp. 164-182. ISSN 0302-2838

Tsang, D.S. orcid.org/0000-0002-9762-6901, Khandwala, M.M., Liu, Z.A. et al. (13 more authors) (2022) Neurocognitive Performance in Adults Treated With Radiation for a Primary Brain Tumor. Advances in Radiation Oncology, 7 (6). 101028. ISSN 2452-1094

Tvilum, M. orcid.org/0000-0001-9250-1678, Knap, M.M., Hoffmann, L. orcid.org/0000-0002-3575-0421 et al. (10 more authors) (2024) Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC. Clinical and Translational Radiation Oncology, 45. 100737. ISSN 2405-6308

Tvilum, M., Lutz, C.M., Knap, M.M. et al. (8 more authors) (2023) Different benefits of adaptive radiotherapy for different histologies of NSCLC. Acta Oncologica, 62 (11). pp. 1426-1432. ISSN 0284-186X

U

Unni, E., Coles, T., Lavallee, D.C. et al. (3 more authors) (2023) Patient adherence to patient-reported outcome measure (PROM) completion in clinical care: current understanding and future recommendations. Quality of Life Research, 33. pp. 281-290. ISSN 0962-9343

Unni, E., Coles, T., Lavallee, D.C. et al. (3 more authors) (2024) Patient adherence to patient-reported outcome measure (PROM) completion in clinical care: current understanding and future recommendations. Quality of Life Research, 33. pp. 281-290. ISSN 0962-9343

V

Vasquez Osorio, E., Mayo, C., Jackson, A. et al. (1 more author) (2023) Challenges of re-irradiation: A call to arms for physicists - and radiotherapy vendors. Radiotherapy and Oncology, 182. 109585. ISSN 0167-8140

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G., Brown, S. et al. (24 more authors) (2023) Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM). Journal of Clinical Oncology. ISSN 0732-183X

Velikova, G. orcid.org/0000-0003-1899-5942, Bedding, C., Absolom, K. orcid.org/0000-0002-5477-6643 et al. (14 more authors) (2024) (208.3) Development of EORTC quality of life questionnaire for metastatic breast cancer patients (EORTC QLQ-MBR44). In: Quality of Life ResearchS. 31st Annual Conference of the International Society for Quality of Life Research, 13 Oct 2024, Cologne, Germany. Springer , S47-S48.

Velikova, G. orcid.org/0000-0003-1899-5942, Morden, J.P., Haviland, J.S. et al. (14 more authors) (2023) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology, 24 (12). pp. 1359-1374. ISSN 1470-2045

Voskanyan, V., Marzorati, C., Sala, D. et al. (17 more authors) (2024) Psychosocial factors associated with quality of life in cancer survivors: umbrella review. Journal of Cancer Research and Clinical Oncology, 150. 249. ISSN 0171-5216

van der Weijst, L., Machingura, A., Alanya, A. et al. (21 more authors) (2024) Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs. European Journal of Cancer, 212. 114313. ISSN 0959-8049

W

Wagner, S.J., Reisenbüchler, D., West, N.P. et al. (46 more authors) (2023) Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study. Cancer Cell, 41. ISSN 1535-6108

Wah, T.M., Lenton, J., Smith, J. et al. (7 more authors) (2021) Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience. European Radiology, 31 (10). pp. 7491-7499. ISSN 0938-7994

Walker, K. orcid.org/0000-0001-6922-9100, Hinsley, S., Phillip, R. orcid.org/0000-0002-9604-9276 et al. (6 more authors) (2022) Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE. JCO Precision Oncology, 6 (6). e2200133. ISSN 2473-4284

Warrington, L. orcid.org/0000-0002-8389-6134, Absolom, K. orcid.org/0000-0002-5477-6643, Baxter, P. orcid.org/0000-0003-2699-3103 et al. (16 more authors) (2024) Quality of life, healthcare usage and finances of UK cancer survivors five years post-diagnosis: a matched controlled study. Journal of Cancer Survivorship. ISSN 1932-2259

Warrington, L. orcid.org/0000-0002-8389-6134, Holmes, M., Gibson, A. et al. (13 more authors) (2024) Patient and clinician perspectives of an eHealth intervention for supporting cancer treatment in the UK: mixed methods evaluation of the eRAPID randomised controlled trial. BMJ Open, 14 (11). e078283. ISSN 2044-6055

Williams, C. orcid.org/0000-0002-1574-653X, Elliott, F., Shires, M. et al. (17 more authors) (2023) Association between artificial intelligence (AI) -assisted tumor AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): An observational cohort study. In: Journal of Clinical Oncology. 2023 ASCO Gastrointestinal Cancers Symposium, 19-21 Jan 2023, San Francisco, USA. American Society of Clinical Oncology , p. 203.

Williams, C. orcid.org/0000-0002-1574-653X, Gray, R.G., Shires, M. et al. (17 more authors) (2023) Artificial intelligence-assisted evaluation of tumor infiltrating CD3+ and CD8+ T cells for prognostication and prediction of benefit from adjuvant chemotherapy in early stage colorectal cancer (CRC): A retrospective analysis of the QUASAR trial. In: Journal of Clinical Oncology. 2023 ASCO Gastrointestinal Cancers Symposium, 19-21 Jan 2023, San Francisco, USA. American Society of Clinical Oncology , p. 204.

Williams, C. orcid.org/0000-0002-1574-653X, Saunderson, C., Liu, J. et al. (4 more authors) (2022) Cardiac toxicities of fluoropyrimidine chemotherapy: A literature review and evaluation of current practice at a large U.K. cancer center. In: Journal of Clinical Oncology. 2022 ASCO Gastrointestinal Cancers Symposium, 20-22 Jan 2022, San Francisco, USA. American Society of Clinical Oncology , p. 72.

Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.

Williams, C. orcid.org/0000-0002-1574-653X, White, M., Platt, J.R. et al. (14 more authors) (2023) The FOxTROT platform: Clinical trials and exploratory research for personalization of neoadjuvant (NA) therapy in locally advanced colon cancer (LACC)—ISRCTN83842641. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Elliott, F. orcid.org/0000-0002-3239-6914, Sapanara, N. orcid.org/0009-0005-0994-837X et al. (51 more authors) (2023) Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer. Clinical Cancer Research, 29 (20). pp. 4153-4165. ISSN 1078-0432

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Gray, R., Hills, R.K. et al. (22 more authors) (2024) Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial. Journal of Clinical Oncology, 42 (29). pp. 3430-3442. ISSN 0732-183X

Williams, C.J.M. orcid.org/0000-0002-1574-653X and Seligmann, J.F. orcid.org/0000-0003-4379-6005 (2024) Big Data and Colorectal Cancer: the Revolution will be Personalised. Clinical Oncology, 36 (4). pp. 206-210. ISSN 0936-6555

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Elliott, F. et al. (24 more authors) (2021) Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer. Clinical Cancer Research, 27 (12). pp. 3422-3431. ISSN 1078-0432

Willmann, J., Appelt, A.L. orcid.org/0000-0003-2792-9218, Balermpas, P. et al. (13 more authors) (2023) Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E²-RADIatE platform. Radiotherapy and Oncology, 189. 109947. ISSN 0167-8140

Wintner, L., Gross, F., Peacock, R. et al. (5 more authors) (2024) Seeing is Believing: Exploring Interpretation Accuracy of PRO Data Visualisations by Patients, Healthcare Professionals, and other Stakeholders. In: Quality of Life Research. 31st Annual Conference of the International Society for Quality of Life Research, 13-16 Oct 2024, Cologne, Germany. Springer , S222-S223.

Wojcik, Z. orcid.org/0009-0007-6214-7736, Dimitrova, V. orcid.org/0000-0002-7001-0891, Warrington, L. orcid.org/0000-0002-8389-6134 et al. (2 more authors) (2024) Using Machine Learning to Predict Unplanned Hospital Utilisation and Chemotherapy Management from Patient-Reported Outcome Measures. JCO Clinical Cancer Informatics, 8. e2300264. ISSN 2473-4276

Wójcik, Z., Dimitrova, V. orcid.org/0000-0002-7001-0891, Warrington, L. orcid.org/0000-0002-8389-6134 et al. (2 more authors) (2024) Patient-Centric Approach for Utilising Machine Learning to Predict Health-Related Quality of Life Changes During Chemotherapy. In: Finkelstein, J., Moskovitch, R. and Parimbelli, E., (eds.) Artificial Intelligence in Medicine. 22nd International Conference, AIME 2024, 09-12 Jul 2024, Salt Lake City, UT, USA. Lecture Notes in Computer Science, 14844 . Springer Nature , pp. 101-116. ISBN 978-3-031-66538-7

Y

Young, T., Velikova, G. orcid.org/0000-0003-1899-5942, Liegl, G. et al. (2 more authors) (2024) EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population. European Journal of Cancer, 204. 113927. ISSN 0959-8049

Z

Zhong, J. orcid.org/0000-0001-5325-3739, Kobus, M. orcid.org/0000-0002-1290-0626, Maitre, P. et al. (9 more authors) (2023) MRI-guided Pelvic Radiation Therapy: A Primer for Radiologists. RadioGraphics, 43 (11). ARTN e230052. ISSN 0271-5333

Ö

Ödén, J., Eriksson, K., Svensson, S. et al. (6 more authors) (2024) Technical note: Optimization functions for re‐irradiation treatment planning. Medical Physics, 51 (1). pp. 476-484. ISSN 0094-2405